Bruker ROE 2010-2023 | BRKR
Current and historical return on equity (ROE) values for Bruker (BRKR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Bruker ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-12-31 |
$0.43B |
$1.40B |
33.75% |
| 2023-09-30 |
$0.32B |
$1.23B |
26.57% |
| 2023-06-30 |
$0.32B |
$1.25B |
28.21% |
| 2023-03-31 |
$0.31B |
$1.20B |
29.32% |
| 2022-12-31 |
$0.30B |
$1.13B |
29.05% |
| 2022-09-30 |
$0.28B |
$0.95B |
27.27% |
| 2022-06-30 |
$0.28B |
$0.98B |
26.25% |
| 2022-03-31 |
$0.28B |
$1.03B |
26.82% |
| 2021-12-31 |
$0.28B |
$1.09B |
26.65% |
| 2021-09-30 |
$0.27B |
$1.09B |
26.69% |
| 2021-06-30 |
$0.24B |
$1.02B |
24.20% |
| 2021-03-31 |
$0.20B |
$0.98B |
21.33% |
| 2020-12-31 |
$0.16B |
$0.97B |
16.77% |
| 2020-09-30 |
$0.16B |
$0.96B |
17.03% |
| 2020-06-30 |
$0.17B |
$0.91B |
18.31% |
| 2020-03-31 |
$0.18B |
$0.93B |
19.96% |
| 2019-12-31 |
$0.20B |
$0.92B |
22.22% |
| 2019-09-30 |
$0.21B |
$0.86B |
23.31% |
| 2019-06-30 |
$0.19B |
$0.87B |
21.47% |
| 2019-03-31 |
$0.18B |
$0.92B |
21.30% |
| 2018-12-31 |
$0.18B |
$0.91B |
21.66% |
| 2018-09-30 |
$0.10B |
$0.83B |
12.51% |
| 2018-06-30 |
$0.09B |
$0.79B |
12.07% |
| 2018-03-31 |
$0.08B |
$0.79B |
11.10% |
| 2017-12-31 |
$0.08B |
$0.73B |
10.64% |
| 2017-09-30 |
$0.15B |
$0.74B |
20.63% |
| 2017-06-30 |
$0.16B |
$0.76B |
22.29% |
| 2017-03-31 |
$0.15B |
$0.73B |
21.89% |
| 2016-12-31 |
$0.16B |
$0.69B |
22.36% |
| 2016-09-30 |
$0.15B |
$0.70B |
20.90% |
| 2016-06-30 |
$0.11B |
$0.67B |
15.56% |
| 2016-03-31 |
$0.12B |
$0.71B |
15.98% |
| 2015-12-31 |
$0.10B |
$0.73B |
13.64% |
| 2015-09-30 |
$0.07B |
$0.77B |
8.84% |
| 2015-06-30 |
$0.06B |
$0.77B |
7.93% |
| 2015-03-31 |
$0.06B |
$0.72B |
6.89% |
| 2014-12-31 |
$0.06B |
$0.77B |
6.83% |
| 2014-09-30 |
$0.07B |
$0.81B |
7.73% |
| 2014-06-30 |
$0.08B |
$0.89B |
9.10% |
| 2014-03-31 |
$0.08B |
$0.87B |
10.43% |
| 2013-12-31 |
$0.08B |
$0.85B |
10.50% |
| 2013-09-30 |
$0.06B |
$0.78B |
7.98% |
| 2013-06-30 |
$0.08B |
$0.72B |
11.48% |
| 2013-03-31 |
$0.07B |
$0.69B |
9.92% |
| 2012-12-31 |
$0.08B |
$0.71B |
11.51% |
| 2012-09-30 |
$0.10B |
$0.70B |
15.85% |
| 2012-06-30 |
$0.08B |
$0.64B |
13.27% |
| 2012-03-31 |
$0.10B |
$0.66B |
15.23% |
| 2011-12-31 |
$0.09B |
$0.63B |
15.14% |
| 2011-09-30 |
$0.08B |
$0.60B |
14.06% |
| 2011-06-30 |
$0.09B |
$0.63B |
16.01% |
| 2011-03-31 |
$0.09B |
$0.57B |
17.95% |
| 2010-12-31 |
$0.10B |
$0.53B |
20.52% |
| 2010-09-30 |
$0.11B |
$0.49B |
25.23% |
| 2010-06-30 |
$0.10B |
$0.41B |
24.38% |
| 2010-03-31 |
$0.09B |
$0.42B |
23.00% |
| 2009-12-31 |
$0.08B |
$0.42B |
22.69% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.947B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
